39 0

Thermo-reversible flurbiprofen liquid suppository with HP-beta-CD as a solubility enhancer: improvement of rectal bioavailability

Title
Thermo-reversible flurbiprofen liquid suppository with HP-beta-CD as a solubility enhancer: improvement of rectal bioavailability
Author
김진기
Keywords
Hydroxypropyl-beta-cyclodextrin; Thermo-reversible liquid suppository; Poloxamer; Bioavailability
Issue Date
2009-03
Publisher
SPRINGER
Citation
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, v. 64, No. 3-4, Page. 265-272
Abstract
The purpose of this work was to develop a thermo-reversible flurbiprofen liquid suppository base composed of poloxamer and sodium alginate for the improvement of rectal bioavailability of flurbiprofen. Cyclodextrin derivatives such as alpha-, beta-, gamma-cyclodextrin and hydroxypropyl-beta-cyclodextrin (HP-beta-CD) were used to enhance the aqueous solubility of flurbiprofen. The effects of HP-beta-CD and flurbiprofen on the physicochemical properties of liquid suppository were then investigated. Pharmacokinetic studies were performed after rectal administration of flurbiprofen liquid suppositories with and without HP-beta-CD or after intravenous administration of commercial Lipfen(A (R)) (flurbiprofen axetil-loaded emulsion) to rats, and their pharmcokinetic parameters were compared. HP-beta-CD decreased the gelation temperature and reinforced the gel strength and bioadhesive force of liquid suppository, while flurbiprofen was opposed to HP-beta-CD. Thermo-reversible flurbiprofen liquid suppository showed the physicochemical properties suitable for rectal administration. The flurbiprofen liquid suppository with HP-beta-CD showed significantly higher plasma levels, AUC and C-max of flurbiprofen than those of the liquid suppository without HP-beta-CD, indicating that flurbiprofen could be well absorbed due to the enhanced solubility by formation of inclusion complex. Moreover, the flurbiprofen liquid suppository with HP-beta-CD showed an excellent bioavailability in that the AUC of flurbiprofen after its rectal administration was not significantly different from that after intravenous administration of commercial Lipfen(A (R)). It is concluded that HP-beta-CD could be a preferable solubility enhancer for the development of liquid suppository containing poorly water-soluble drugs.
URI
https://link.springer.com/article/10.1007/s10847-009-9560-7http://repository.hanyang.ac.kr/handle/20.500.11754/74679
ISSN
1388-3127
DOI
10.1007/s10847-009-9560-7
Appears in Collections:
COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE